Select a State

Global health R&D delivers for New Hampshire

US government investment in global health R&D has delivered

$19.6 million
to New Hampshire research institutions
200+ new jobs
for New Hampshire

Neglected diseases in New Hampshire

Chikungunya cases
27
Dengue cases
13
HIV diagnoses
361
Malaria cases
49
Tuberculosis cases
119
West Nile cases
3
Zika cases
12

New Hampshire's top USG-funded global health R&D institutions

Dartmouth College
$19.6 million

New Hampshire industry in global health R&D

Celdara Medical
Location(s):
Lebanon
Symbiora
Location(s):
Grantham
Westat
Location(s):
Lebanon

New Hampshire's top areas of global health R&D by USG funding

29.0%
HIV/AIDS
66.6%
Diarrheal diseases
4.4%
Other
Non-allocable

Global health R&D at work in New Hampshire

Cholera is an acute diarrheal disease that can kill within hours. Highly contagious, the disease is spread mainly by contaminated food and water. The disease has been around since ancient times, yet it remains a threat in many parts of the world. There are vaccines to prevent it; Since 2013, more than 15 million doses have been used in mass vaccination campaigns. But there is no cure. There remains millions of cases each year and an estimated 21,000 to 143,000 deaths from the disease. Researchers at the Dartmouth Geisel School of Medicine are working to end that. Their unique approach is to look at ways to turn off the genes that make cholera dangerous to humans. The drug therapy under development at Dartmouth aims not to kill the bacteria, but to render them harmless, making them less likely to mutate and become resistant to the drug.

Footnotes